Klox Technologies Limited – Trademark Portfolio

Entity Type: 99

Klox Technologies Limited holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PHOVIA. The owner is based in Dublin 2.

70 Sir John Rogerson's Quay

Dublin 2 , IE

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PHOVIA
PHOVIA
Registered 2017
PHOVIA
PHOVIA
Cancelled 2017
PHOVIA
PHOVIA
Registered 2016
PHOVIA
PHOVIA
Cancelled 2016

Trademark Classifications

Klox Technologies Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Klox Technologies Limited have?

Klox Technologies Limited has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.

What trademark classes does Klox Technologies Limited file in?

Klox Technologies Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Klox Technologies Limited's most well-known trademarks?

Klox Technologies Limited's registered trademark portfolio includes well-known marks such as PHOVIA. These are among 2 currently registered trademarks in the portfolio.

What is Klox Technologies Limited's trademark registration success rate?

Klox Technologies Limited has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.